Skip to content

A Multicenter Retrospective Review of Management Strategies in Small Bowel Obstruction

A Multicenter Retrospective Review of Management Strategies in Small Bowel Obstruction

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06223620
Enrollment
504
Registered
2024-01-25
Start date
2018-07-30
Completion date
2019-12-31
Last updated
2026-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SBO - Small Bowel Obstruction

Brief summary

The objective of the study is to review performance of water soluble contrast study in patients admitted with Small Bowel Obstruction(SBO), will improve quality and safety, and decrease length of stay and morbidity.

Detailed description

Performance of contrast study has been a part of the protocols at multiple institutions of the southwestern surgical congress. Plan to perform a retrospective review of management protocols at these institutions. Wish to know whether the implementation of a standardized, protocol-driven pattern of practice involving the performance of water soluble contrast study in patients admitted with SBO, will improve quality and safety, and decrease length of stay and morbidity. The objective of the study is to review performance of water soluble contrast study in patients admitted with SBO, will improve quality and safety, and decrease length of stay and morbidity. Performance of contrast study has been a part of the protocols at multiple institutions of the southwestern surgical congress. Hypothesize that implementation of a standardized, protocol-driven pattern of practice involving the performance of water soluble contrast study in patients admitted with SBO, will improve quality and safety, and decrease length of stay and morbidity.

Interventions

OTHERreview performance of water soluble contrast

review performance of water soluble contrast study in patients admitted with SBO, will improve quality and safety, and decrease length of stay and morbidity.

Sponsors

Methodist Health System
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* • Adults aged 18-89 years of age * Patients presenting with SBO

Exclusion criteria

* • Prisoners * Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Morbidity and length of stay1 yearMorbidity and length of stay

Secondary

MeasureTime frameDescription
Patient demographics1 yearnumber of patients (age, sex, weight, height)
admit date1 yearNumber of patients admitting to the hospital
discharge date1 yearnumber of patients discharging
admission service1 yearNumber of services related to admissions
Aspirin(ASA )class1 yearnumber of aspirin class
comorbidities1 yearnumber of comorbidities associated
surgical history1 yearnumber of surgeries in the past
labs1 yearnumber of labs done
time of contrast given1 yearrate of Contrast given

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORMichael Truitt, MD

The Methodist Hospital Research Institute

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026